Viewing StudyNCT00022607



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00022607
Status: COMPLETED
Last Update Posted: 2013-06-24
First Post: 2001-08-10

Brief Title: Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: California Cancer Consortium
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma and Plasma Cell Neoplasm
Keywords:
Name View
stage III multiple myeloma View
refractory multiple myeloma View
stage I multiple myeloma View
stage II multiple myeloma View